PDS Biotechnology (PDSB) Return on Equity [ROE] (2015 - 2026)
PDS Biotechnology's Return on Equity [ROE] was -1260.81% in Q2 2026, down 1069.78 percentage points from -191.03% a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at PDS Biotechnology came in at -243.94%, down 77.29 percentage points from FY2024.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -167.47 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -166.65% in FY2024 (-44.19 pp), -122.46% in FY2023 (-46.25 pp), -76.21% in FY2022 (-38.76 pp) and -37.46% in FY2021 (+39.02 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q4 2015.
- Compared with a year earlier, Return on Equity [ROE] was higher in 1 of the last seven quarters, with an average year-over-year change of -209.70 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 49.07 percentage points); the worst was Q2 2026 (a drop of 1069.78 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | PDS Biotechnology | 57.60 Mn | -22.61 Mn | - | -21,522.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21,522.23% |
| Mar 31, 2026 | -507.52% |
| Dec 31, 2025 | -368.83% |
| Sep 30, 2025 | -274.54% |
| Jun 30, 2025 | -191.02% |
| Mar 31, 2025 | -171.61% |
| Dec 31, 2024 | -183.44% |
| Sep 30, 2024 | -153.28% |
| Jun 30, 2024 | -119.47% |
| Mar 31, 2024 | -138.63% |
| Dec 31, 2023 | -169.68% |
| Sep 30, 2023 | -179.81% |
| Jun 30, 2023 | -130.03% |
| Mar 31, 2023 | -98.91% |
| Dec 31, 2022 | -89.73% |
| Sep 30, 2022 | -56.94% |
| Jun 30, 2022 | -51.40% |
| Mar 31, 2022 | -37.53% |
| Dec 31, 2021 | -25.82% |
| Sep 30, 2021 | -20.77% |
API Access
PDS Biotechnology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();